Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Angiol Sosud Khir ; 24(4): 177-182, 2018.
Artigo em Russo | MEDLINE | ID: mdl-30531786

RESUMO

Presented in the review is the data concerning contemporary criteria for assessing the degree of chronic lower limb ischaemia and quality of the treatment performed. Problems regarding objectivization of the degree of an ischaemic lesion of an extremity and assessment of quality of conservative treatment still remain unresolved. Currently, in the world practice along with instrumental methods (assessment of the ankle-brachial index) subjective criteria are mainly employed: assessment of pain-free walking distance or maximum distance walked. In order to work out appropriate regiments of conservative treatment and compare efficacy of various drugs for treatment of chronic lower limb ischaemia and, in particular, intermittent claudication, it is necessary to use objective criteria. Detailed consideration is hence given to the possibilities of using morphological, biochemical and histological criteria such as determination of vascular endothelial growth factor A (VEGF-A) in peripheral blood and determination of apoptosis markers (BNIP3) and hypoxia-inducible factor (HIF-1) in a biopsy sample of the gastrocnemius muscle of the ischaemized extremity.


Assuntos
Arteriopatias Oclusivas/terapia , Isquemia , Extremidade Inferior/irrigação sanguínea , Administração dos Cuidados ao Paciente/métodos , Arteriopatias Oclusivas/metabolismo , Arteriopatias Oclusivas/fisiopatologia , Humanos , Isquemia/diagnóstico , Isquemia/etiologia , Extremidade Inferior/fisiopatologia , Resultado do Tratamento
2.
Angiol Sosud Khir ; 22(4): 169-175, 2016.
Artigo em Russo | MEDLINE | ID: mdl-27935898

RESUMO

With due regard to the requirements of evidence-based medicine, the article contains a review of present-day positions concerning conservative therapy in patients with peripheral artery diseases and chronic arterial ischaemia, represented in the latest Russian and foreign consensus documents, showing importance of bringing the basic provisions of the consensus documents to the notice of practical health-care providers with the aim of working out more effective therapeutic regimens. Some sections of the guidelines regarding the duration of treatment, among the number, require definite specification with the wording of more clear-cut practical conclusions.


Assuntos
Tratamento Conservador/métodos , Doença Arterial Periférica , Doença Crônica , Terapia por Exercício/métodos , Promoção da Saúde/métodos , Humanos , Isquemia/etiologia , Isquemia/fisiopatologia , Isquemia/prevenção & controle , Conduta do Tratamento Medicamentoso , Doença Arterial Periférica/complicações , Doença Arterial Periférica/diagnóstico , Doença Arterial Periférica/terapia , Guias de Prática Clínica como Assunto
3.
Angiol Sosud Khir ; 20(1): 8-14, 2014.
Artigo em Russo | MEDLINE | ID: mdl-24722015

RESUMO

Presented in the article are the results of studying antiaggregate activity of acetylsalicylic acid and clopidogrel in a total of 36 patients suffering from various-severity chronic arterial insufficiency of lower limbs on the background of atherosclerosis obliterans. The study was conducted prior to treatment for correct selection of a particular antiplatelet agent. The obtained results showed that clopidogrel was not always more efficient than acetylsalicylic acid, since there is individual sensitivity of each patients to a particular antiplatelet agent. Therefore, an individual approach is necessary to conservative therapy of arterial insufficiency of lower limbs. For some patients it is preferable to administer clopidogrel, for others - acetylsalicylic acid. In a series of cases combined treatment is justified, while some patients having low sensitivity to both acetylsalicylic acid and clopidogrel require careful selection of alternative agents influencing other thrombocyte receptors.


Assuntos
Aspirina , Doença Arterial Periférica/tratamento farmacológico , Agregação Plaquetária/efeitos dos fármacos , Ticlopidina/análogos & derivados , Idoso , Aspirina/administração & dosagem , Aspirina/efeitos adversos , Aspirina/farmacocinética , Clopidogrel , Feminino , Humanos , Extremidade Inferior/irrigação sanguínea , Masculino , Pessoa de Meia-Idade , Seleção de Pacientes , Doença Arterial Periférica/sangue , Doença Arterial Periférica/diagnóstico , Doença Arterial Periférica/fisiopatologia , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/efeitos adversos , Inibidores da Agregação Plaquetária/farmacocinética , Índice de Gravidade de Doença , Equivalência Terapêutica , Ticlopidina/administração & dosagem , Ticlopidina/efeitos adversos , Ticlopidina/farmacocinética , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA